Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Hicklin D J; Wu Y; Yanase K; Namisaki T; Yamazaki M; Tsujinoue H; Imazu H; Masaki T; Fukui H
September 2003
Gut;Sep2003, Vol. 52 Issue 9, p1347
Academic Journal
BACKGROUND: It has been shown that expression of the potent angiogenic factor, vascular endothelial growth factor (VEGF), and its receptors, flt-1 (VEGFR-1) and KDR/Flk-1 (VEGFR-2), increased during the development of liver fibrosis. AIMS: To elucidate the in vivo role of interaction between VEGF and its receptors in liver fibrogenesis. METHODS: A model of CCl(4) induced hepatic fibrosis was used to assess the role of VEGFR-1 and VEGFR-2 by means of specific neutralising monoclonal antibodies (R-1mAb and R-2mAb, respectively). R-1mAb and R-2mAb were administered after two weeks of treatment with CCl(4), and indices of fibrosis were assessed at eight weeks. RESULTS: Hepatic VEGF mRNA expression significantly increased during the development of liver fibrosis. Both R-1mAb and R-2mAb treatments significantly attenuated the development of fibrosis associated with suppression of neovascularisation in the liver. Hepatic hydroxyproline and serum fibrosis markers were also suppressed. Furthermore, the number of alpha-smooth muscle actin positive cells and alpha1(I)-procollagen mRNA expression were significantly suppressed by R-1mAb and R-2mAb treatment. The inhibitory effect of R-2mAb was more potent than that of R-1mAb, and combination treatment with both mAbs almost completely attenuated fibrosis development. Our in vitro study showed that VEGF treatment significantly stimulated proliferation of both activated hepatic stellate cells (HSC) and sinusoidal endothelial cells (SEC). VEGF also significantly increased alpha1(I)-procollagen mRNA expression in activated HSC. CONCLUSIONS: These results suggest that the interaction of VEGF and its receptor, which reflected the combined effects of both on HSC and SEC, was a prerequisite for liver fibrosis development.


Related Articles

  • Angiogenesis in chronic viral hepatitis. Kukla, Michał; Gabriel, Andrzej; Waluga, Marek; Buldak, Rafał; Mazur, Włodzimierz // Gastroenterologia Polska / Gastroenterology;2009, Vol. 16 Issue 4, p304 

    It is unresolved whether angiogenesis is merely a homeostatic mechanism aimed at ensuring an adequate oxygen supply or one that exerts an additional pathogenic role leading to liver tissue damage. The development of fibrosis and the accumulation of inflammatory cells which occur in viral...

  • Abnormal liver differentiation and excessive angiogenesis in mice lacking Runx3. Lee, Jong-Min; Lee, Dong-Joon; Bae, Suk-Chul; Jung, Han-Sung // Histochemistry & Cell Biology;May2013, Vol. 139 Issue 5, p751 

    Runt-related transcription factor 3 (Runx3) is essential for normal mouse development, and Runx3 knock-out (KO) mice (FVB strain), which die within 24 h after birth, show various organ defects, such as lung hyperplasia. For proper early liver development, angiogenesis and liver cell...

  • Biological activities of fibroblast growth factor-2 in the adult myocardium. Detillieux, Karen A.; Sheikh, Farah; Kardami, Elissavet; Cattini, Peter A. // Cardiovascular Research;Jan2003, Vol. 57 Issue 1, p8 

    Fibroblast growth factor-2 (FGF-2) is a potent regulator of many cellular functions and phenomena, including cell proliferation, differentiation, survival, adhesion, migration, motility and apoptosis, and processes such as limb formation, wound healing, tumorigenesis, angiogenesis,...

  • Hereditary hemorrhagic telangiectasia: an update on transforming growth factor � signaling in vasculogenesis and angiogenesis. van den Driesche, Sander; Mummery, Christine L.; Westermann, Cornelius J.J. // Cardiovascular Research;Apr2003, Vol. 58 Issue 1, p20 

    Hereditary hemorrhagic telangiectasia (HHT) is a vascular disorder in humans which has been mapped to two genes, endoglin and activin receptor-like kinase-1 (ALK-1) both of which mediate signaling by transforming growth factor � ligands in vascular endothelial cells. Animal models have...

  • Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model. Babaei, Saeid; Stewart, Duncan J. // Cardiovascular Research;Jul2002, Vol. 55 Issue 1, p190 

    Objective: Angiogenesis is a complex multistep process that involves endothelial cell (EC) migration, proliferation and differentiation into vascular tubes. NO has been reported to be a downstream mediator in the angiogenic response to a variety of growth factors, but the mechanisms by...

  • ERRATUM.  // Nature Medicine;Mar2000, Vol. 6 Issue 3, p356 

    Presents an erratum for the article 'PR39, a peptide regulator of angiogenesis,' published in the March 2000 issue of 'Nature Medicine,' volume 6, number 3.

  • Polymeric system for dual growth factor delivery. Richardson, Thomas P.; Peters, Martin C.; Ennett, Alessandra B.; Mooney, David J. // Nature Biotechnology;Nov2001, Vol. 19 Issue 11, p1029 

    The development of tissues and organs is typically driven by the action of a number of growth factors. However, efforts to regenerate tissues (e.g., bone, blood vessels) typically rely on the delivery of single factors, and this may partially explain the limited clinical utility of many current...

  • Corrigendum: LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling. Wang, Xiaomeng; Abraham, Sabu; McKenzie, Jenny A. G.; Jeffs, Natasha; Swire, Matthew; Tripathi, Vineeta B.; Luhmann, Ulrich F. O.; Lange, Clemens A. K.; Zhai, Zhenhua; Arthur, Helen M.; Bainbridge, James W. B.; Moss, Stephen E.; Greenwood, John // Nature;9/26/2013, Vol. 501 Issue 7468, p578 

    A correction to the article "LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling" that was published in the 2013 issue of the periodical is presented.

  • Timeline: VEGF and the quest for tumour angiogenesis factors. Ferrara, Napoleone // Nature Reviews Cancer;Oct2002, Vol. 2 Issue 10, p795 

    The ability of tumours to induce new blood-vessel formation has been a major focus of cancer research over the past few decades, and vascular endothelial growth factor (VEGF) is now known to be central to this process. The quest for VEGF and other factors that promote tumour angiogenesis was...


Read the Article


Sign out of this library

Other Topics